Paraoxonase-1 (PON1), a major anti-oxidant enzyme, has been reported to contribute to the pathogenesis of asthma [11] and many other diseases, including rheumatoid arthritis [12,13], diabetes [14], systemic lupus erythematosus [15], and psoriasis [16]. Here, PON1 is linked to systemic lupus erythematosus.